DC-T细胞轴是治疗非小细胞肺癌的有效标
Shuangcui Wang1,2,3, Guan Zhang1,2,3, Qian Cui1,2,3
1Department of Oncology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Immunity, inflammation and disease
|November 29, 2023
概括
增强树突细胞 (DC) 和T细胞相互作用可以改善对非小细胞肺癌 (NSCLC) 的免疫反应. 本综述探讨了NSCLC治疗结果中的DC-T细胞交叉.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 癌症研究 癌症研究
背景情况:
- 树突细胞 (DC) -T细胞轴连接先天性和适应性免疫.
- 成熟的抗原呈现DCs启动抗瘤免疫反应.
- 了解DC-T细胞相互作用对于癌症免疫治疗至关重要.
研究的目的:
- 审查DC-T细胞相互作用在非小细胞肺癌 (NSCLC) 治疗中的作用.
- 探索如何增强这个轴可以提高NSCLC的抗瘤免疫力.
主要方法:
- 关于NSCLC中DC-T细胞相互作用的研究的文献综述.
- 分析DC-T细胞交叉对治疗疗效的影响.
主要成果:
- 在NSCLC中,DC-T细胞相互作用对于启动和塑造抗瘤免疫反应至关重要.
- 调节DC和T细胞交叉交互是一种有前途的治疗策略.
结论:
- 优化DC-T细胞轴是改善NSCLC免疫疗法的关键策略.
- 对DC-T细胞调节的进一步研究可能会导致新的NSCLC治疗方法.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Tumor Immunotherapy
529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529


